Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1997-08-15
2000-01-04
Spivack, Phyllis G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
A61K 31135
Patent
active
060110708
ABSTRACT:
Disclosed is a method of treating an individual who abuses cocaine by administering to the individual a therapeutically effective amount of an N,N-dialkyl 3-phenyl-1-indanamine or a mixture of N,N-dialkyl 3-phenyl-1-indanamines. Also disclosed is a method of treating an individual with Parkinson's disease or attention deficit hyperactivity disorder by administering to the individual a therapeutically effective amount of an N,N-dialkyl 3-phenyl-1-indanamine or a mixture of N,N-dialkyl 3-phenyl-1-indanamines.
REFERENCES:
patent: 5639913 (1997-06-01), Lidor et al.
S. Rosonzweig-Lipson et al., "Stereoselective Behavioral Effects of Lu 19-005 in Monkeys: Relation to Binding at Cocaine Recognition Sites," Psychopharmacology, 107:186-194 (1992).
K. P. Bogeso, et al., 3-Phenyl-1-Indanamines Potential Antidepressant Activity and Potent Inhibition of Dopamine, Norepinephrine and Serotonin Uptake, J. Med. Chem., 28:1817-1828 (1985).
S. Izenwasser, et al., "Differential Relationships Among Dopamine Transporter Affinities and Stimulant Potencies of Various Uptake Inhibitors," European Journal of Pharmacology, 263:277-283 (1994).
N. Tomita, "Structure--Activity Relationships of Dopamine--and Norepinephrine-Uptake Inhibitors," Chem. Pharm. Bull. 38(6):1563-1569 (1990).
M. Froimowitz, et al., "Slow Onset, Long Lasting Dopamine Reuptake Blockers as Potential Medications for the Treatment of Cocaine Abuse," 1996 Annual Meeting, Washington, D.C., Nov. 16-21, 1996, Abstract, Mail Date: Aug. 18, 1996.
M. Froimowitz, et al., "Effects of a Slow-Onset, Long-Acting Dopamine Reuptake Blocker on Cacaine Self-Administration and on Nucleus Accumbens Dopamine," Society for Neuroscience Abstracts, vol. 23, Part. 1, 27.sup.th Annual Meeting, New Orleans, LA, Oct. 25-30, 1997, Mail Date: Aug. 25, 1997.
Eliot L. Gardner, et al., Poster presented at meetings of The College on Problems of Drug Dependence, Nashville, Tennessee, Jun. 1997.
Froimowitz Mark
Wu Kuo-Ming
Allelix-Pharm-Eco L.P.
Spivack Phyllis G.
LandOfFree
Slow-onset, long-lasting dopamine reuptake blockers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Slow-onset, long-lasting dopamine reuptake blockers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Slow-onset, long-lasting dopamine reuptake blockers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1073076